Published on 28th May 2009
Bioquell PLC discloses that all the Resolutions set out in the Notice of AGM were passed at the Annual General Meeting (“AGM”) held earlier today.
Published on 19th May 2009
Bioquell PLC announces its Interim Management Statement for the period from 1 January, 2009 to 18 May, 2009.
Published on 28th April 2009
Nick Adams, Chief Executive of Bioquell PLC informed the Company that he had exercised 80,000 options over Shares. Mark Bodeker, Chief Operating Officer, informed the Company that he had exercised 80,000 options over Shares.
Published on 15th April 2009
The Annual General Meeting of Bioquell PLC will take place on Thursday 28 May at the Company’s offices, 52 Royce Close, West Portway, Andover, Hampshire, SP10 3TS.
Published on 27th March 2009
Bioquell PLC announces that Nicholas Adams, Chief Executive, and Mark Bodeker, Chief Operating Officer and Finance Director, have been awarded options (“Options”), with vesting preconditions, over ordinary Bioquell shares.
Published on 24th March 2009
The Bioquell annual report 2008 has now been published.
Published on 24th March 2009
Bioquell PLC announces its results for the year ended 31 December, 2008.
Published on 27th February 2009
Bioquell has won a prestigious award from the Department of Health and NHS Purchasing and Supply Agency (PASA) in recognition of its Hydrogen Peroxide Vapour (HPV) decontamination technology, offering the greatest contribution in controlling Clostridium difficile.
Published on 27th August 2008
Bioquell PLC announces its interim results for the six months ended 30 June 2008.
Published on 16th July 2008
Mr Andrew Muir pursuant to DTR 5.1.2(1) on 15 July 2008 purchased BIOQUELL PLC ordinary shares and his total holding now comprises 2,150,257 Shares representing approximately 5.2% of the issued Share capital.